Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRRK | Common Stock | Award | $0 | +13.5K | $0.00 | 13.5K | Jun 27, 2024 | Direct | F1, F2 | |
holding | SRRK | Common Stock | 6.79M | Jun 27, 2024 | By Samsara BioCapital, L.P. | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRRK | Stock Option (Right to Buy) | Award | $0 | +18K | $0.00 | 18K | Jun 27, 2024 | Common Stock | 18K | $8.36 | Direct | F4 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. |
F2 | Consists of 13,500 RSUs. |
F3 | Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
F4 | Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. |